Intrinsiqq
HeartBeam Inc. logo

HeartBeam Inc. Insider Trading

BEAT

Compare
Last 12 months

Insiders bought 901K and sold 182K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director George De Urioste sold 182K on Dec 18, 2025, 100% of their stake, outside a plan.

Net open-market
+719K
8 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
8 / 1
executives and directors
Last open-market buy
Apr 2026
Apr 16, 2026

Get an email when BEAT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Apr 16
    Richard Ferrari
    Director · bought 57,500 at $0.80
    46K
    25% of stake
  • Apr 16
    Tim Cruickshank
    CFO · bought 31,250 at $0.80
    25K
    76% of stake
  • Apr 16
    Willem Elfrink
    Director · bought 187,500 at $0.80
    150K
    53% of stake
  • Apr 16
    Michael R Jaff
    Director · bought 31,250 at $0.80
    25K
    New position
  • Apr 16
    Branislav Vajdic
    Director · bought 31,250 at $0.80
    25K
    3.6% of stake
  • Apr 16
    Robert Paul Eno
    President · bought 12,500 at $0.80
    10K
    52% of stake
  • Apr 16
    Marga Ortigas-Wedekind
    Director · bought 25,000 at $0.80
    20K
    22% of stake
  • Apr 16
    Mark E Strome
    Director · bought 750,000 at $0.80
    600K
    26% of stake
  • Dec 17, 2025 – Dec 18, 2025No plan
    George De Urioste
    Director · sold 57,146 at avg $3.19
    182K
    100% of stake
  • Dec 17, 2025No plan
    Mark E Strome
    Large holder · sold 250,000 at $3.58
    895K
    7.9% of stake
  • Feb 14, 2025
    Richard Ferrari
    Director · bought 29,412 at $1.70
    50K
    14% of stake
  • Feb 14, 2025
    Tim Cruickshank
    CFO · bought 17,647 at $1.70
    30K
    New position
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BEAT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with BEAT

CompareIntrinsic value
GUTSFractyl Health Inc.
$0.82-14.14%10
OSUROrasure Technologies Inc.
$3.46-4.16%20
BJDXBluejay Diagnostics Inc.
$1.70-5.56%20
USAQQHSLab Inc.
$0.26+0.00%50
RDGLVivos Inc.
$0.04-2.68%40
NSPRInspireMD Inc.
$0.54-12.90%25
NPCENeuroPace Inc.
$7.95-2.33%30
SRTSSensus Healthcare Inc.
$2.27-3.81%18

Spot a number that looks wrong? Check it in BEAT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BEAT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.